Hospital Duran i Reynals /ID# 224007

L'Hospitalet de Llobregat, Barcelona 08907

0 studies enrolling now · 1 studies all time

What they study most

Myeloproliferative Neoplasm

Studies at this site

• A Study Evaluating Safety and Tolerability, and Pharmacokinetics of Navitoclax Monotherapy and in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasm — Running, not enrolling